Merck & Co. (6MK) – cijena dionice i vijesti

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia

Merck & Co. – informacije

Glavni izvršni direktorRobert M Davis

Zaposlenici74 tis.

Osnovano1. sij 1891.

Sjedište-

Sektor-

Web-lokacijamerck.com

Sve vrijednosti su u valuti USD	ruj 2025.	pro 2025.	ožu 2026.	lip 2026.
Prihod	17,28 mlr.	16,40 mlr.	16,29 mlr.	16,61 mlr.
Trošak prodane robe	3,74 mlr.	4,30 mlr.	3,88 mlr.	4,13 mlr.
Trošak prihoda	3,74 mlr.	4,30 mlr.	3,88 mlr.	4,13 mlr.
Izdaci za istraživanje i razvoj	4,00 mlr.	4,00 mlr.	3,56 mlr.	9,74 mlr.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	2,48 mlr.	2,73 mlr.	2,57 mlr.	2,78 mlr.
Poslovni rashod	6,48 mlr.	6,73 mlr.	6,12 mlr.	12,52 mlr.
Ukupni poslovni rashodi	10,23 mlr.	11,02 mlr.	10,00 mlr.	16,65 mlr.
Poslovni prihod	7,05 mlr.	5,38 mlr.	6,29 mlr.	−40,00 mil.
Ostali neposlovni prihod	-	41,00 mil.	42,00 mil.	59,00 mil.
Zarada prije poreza uključujući neuobičajene stavke	6,74 mlr.	3,42 mlr.	−3,53 mlr.	−683,00 mil.
Zarada prije poreza isključujući neuobičajene stavke	6,76 mlr.	4,98 mlr.	5,85 mlr.	−508,00 mil.
Izdaci za porez na dohodak	958,00 mil.	458,00 mil.	709,00 mil.	654,00 mil.
Efektivna porezna stopa	14,20 %	13,39 %	−20,06 %	−95,75 %
Ostali poslovni rashodi	-	-	-	-
Neto dohodak	5,78 mlr.	2,96 mlr.	−4,24 mlr.	−1,34 mlr.
Neto profitna marža	33,49 %	18,07 %	−26,03 %	−8,04 %
Zarada po dionici	2,58	2,04	−1,28	−0,13
Prihod od kamata i ulaganja	96,00 mil.	69,00 mil.	35,00 mil.	35,00 mil.
Izdaci za kamate	−327,00 mil.	−411,00 mil.	−479,00 mil.	−525,00 mil.
Neto izdaci za kamate	−231,00 mil.	−342,00 mil.	−444,00 mil.	−490,00 mil.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	8,15 mlr.	6,79 mlr.	7,69 mlr.	1,43 mlr.
Dobit ili gubitak od prodaje imovine	-	-	-	-

Pitajte bilo što